182 related articles for article (PubMed ID: 33483774)
1. Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study.
Yan W; Wu B; Liao AJ; Yang W; Wang HH
Ann Hematol; 2021 Mar; 100(3):709-714. PubMed ID: 33483774
[TBL] [Abstract][Full Text] [Related]
2. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and diagnosis of pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma: a retrospective analysis of 29 cases].
Li AW; Xu JF; Zhou CC; Wu CY; Wang YL
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):390-3. PubMed ID: 22883464
[TBL] [Abstract][Full Text] [Related]
4. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa-associated lymphoid tissue-derived lymphoma.
Wang L; Ye G; Liu Z; Shi L; Zhan C; Gu J; Luo R; Lin Z; Ge D; Wang Q
Cancer Med; 2019 Dec; 8(18):7660-7668. PubMed ID: 31691549
[TBL] [Abstract][Full Text] [Related]
6. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Japanese population.
Ogusa E; Tomita N; Ishii Y; Takasaki H; Hattori Y; Matsumoto C; Ishigatsubo Y
Hematol Oncol; 2013 Mar; 31(1):18-21. PubMed ID: 22278757
[TBL] [Abstract][Full Text] [Related]
8. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
[TBL] [Abstract][Full Text] [Related]
9. Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
Arkenau HT; Gordon C; Cunningham D; Norman A; Wotherspoon A; Chau I
Leuk Lymphoma; 2007 Mar; 48(3):547-50. PubMed ID: 17454597
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care for orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in Korea throughout 2016: Results from a multicenter cross-sectional cohort study (KROG 16-19).
Lee J; Oh D; Choi BO; Eom KY; Lee JH; Kim JH; Lee SW; Suh YK; Suh CO
Asia Pac J Clin Oncol; 2019 Dec; 15(6):358-363. PubMed ID: 31264373
[TBL] [Abstract][Full Text] [Related]
11. Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era.
Yuda S; Maruyama D; Maeshima AM; Makita S; Kitahara H; Miyamoto KI; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Tajima K; Taniguchi H; Tobinai K
Ann Hematol; 2016 Dec; 95(12):2017-2022. PubMed ID: 27666284
[TBL] [Abstract][Full Text] [Related]
12. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous bilateral spontaneous pneumothorax as the first manifestation of primary pulmonary MALT lymphoma.
Migaou A; Slama N; Njima M; Achour A; Saad AB; Boukhris S; Fahem N; Dimassi S; Laatiri A; Mhammed SC; Rouatbi N; Joobeur S
Pan Afr Med J; 2020; 37():11. PubMed ID: 33062114
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
16. First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J; Paszkiewicz-Kozik E; Michalski W; Rymkiewicz G; Szpila T; Butrym A; Giza A; Zaucha JM; Kalinka-Warzocha E; Wieczorkiewicz A; Zimowska-Curyło D; Knopińska-Posłuszny W; Tyczyńska A; Romejko-Jarosińska J; Dąbrowska-Iwanicka A; Gruszecka B; Jamrozek-Jedlińska M; Borawska A; Hołda W; Porowska A; Romanowicz A; Hellmann A; Stella-Hołowiecka B; Deptała A; Jurczak W
Br J Haematol; 2020 Mar; 188(6):898-906. PubMed ID: 31792945
[TBL] [Abstract][Full Text] [Related]
17. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
[TBL] [Abstract][Full Text] [Related]
18. Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up.
Troch M; Streubel B; Petkov V; Turetschek K; Chott A; Raderer M
Anticancer Res; 2007; 27(5B):3633-7. PubMed ID: 17972528
[TBL] [Abstract][Full Text] [Related]
19. [Six cases of pulmonary MALT lymphoma: a heterogeneous therapeutic management].
Marco S; Thariat J; Poudenx M; Butori C; Mouroux J; Fuzibet JG; Marquette CH; Peyrade F; Thyss A
Rev Pneumol Clin; 2011 Jun; 67(3):174-8. PubMed ID: 21665083
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma].
Tian L; Zhang C; Liu W; Wang X; Zheng W; Xie Y; Lin N; Ying Z; Ping L; Deng L; Song Y; Zhu J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):759-62. PubMed ID: 24844960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
